Neurontin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7256216 VIATRIS Liquid pharmaceutical compositions
May, 2022

(1 year, 4 months ago)



VIATRIS Liquid pharmaceutical compositions
Nov, 2022

(10 months ago)

Neurontin is owned by Viatris.

Neurontin contains Gabapentin.

Neurontin has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Neurontin are:

  • US7256216
  • US7256216*PED

Neurontin was authorised for market use on 02 March, 2000.

Neurontin is available in solution;oral dosage forms.

The generics of Neurontin are possible to be released after 28 November, 2022.

Drugs and Companies using GABAPENTIN ingredient

Market Authorisation Date: 02 March, 2000

Treatment: NA


How can I launch a generic of NEURONTIN before it's drug patent expiration?
More Information on Dosage

NEURONTIN family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic